Tetra Radar · FDA Approvals · Decision date

povetacicept: FDA decision date

Vertex Pharmaceuticals Inc / Ma (VRTX) · 30 November 2026

FDA’s review of our biologics license application for accelerated approval of povetacicept with an assigned PDUFA . target action date of November 30, 2026;.

Source: 10-Q of 3 November 2026

The decision is pending.

A PDUFA date is the date by which the FDA has said it will decide on an application. Dates can move, and a decision is not an approval. Tetra Radar observes public information for research purposes. It does not provide investment advice.

Get the Dispatch free.